Barnik Invest Group Appoints Dr. Benedict Broennimann as Chief Scientific Officer

Stockholm, Sweden – Barnik Invest Group, today announced the appointment of Dr. Benedict Broennimann as Chief Scientific Officer. Dr. Broennimann is a highly accomplished medical and business executive with over 20 years of experience in the Life sciences industry. His extensive expertise and leadership will be invaluable as Barnik Invest Group continues to identify and […]